Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where E. Lynn Zechiedrich is active.

Publication


Featured researches published by E. Lynn Zechiedrich.


Molecular Microbiology | 2002

Control of the AcrAB multidrug efflux pump by quorum-sensing regulator SdiA

Sonia Rahmati; Shirley Yang; Amy L. Davidson; E. Lynn Zechiedrich

SdiA is an Escherichia coli protein that regulates cell division in a cell density‐dependent, or quorum‐sensing, manner. We report that SdiA also controls multidrug resistance by positively regulating the multidrug resistance pump AcrAB. Overproduction of SdiA confers multidrug resistance and increased levels of AcrAB. Conversely, sdiA null mutants are hypersensitive to drugs and have decreased levels of AcrB protein. Our findings provide a link between quorum sensing and multidrug efflux. Combined with previously published reports, our data support a model in which a role of drug efflux pumps is to mediate cell–cell communication in response to cell density. Xenobiotics expelled by pumps may resemble the communication molecules that they normally efflux.


Molecular Microbiology | 2005

A role for topoisomerase III in a recombination pathway alternative to RuvABC

Christopher R. Lopez; Shirley Yang; Richard W. Deibler; Starlight A. Ray; Jeanine M. Pennington; Russell J. DiGate; P. J. Hastings; Susan M. Rosenberg; E. Lynn Zechiedrich

The physiological role of topoisomerase III is unclear for any organism. We show here that the removal of topoisomerase III in temperature sensitive topoisomerase IV mutants in Escherichia coli results in inviability at the permissive temperature. The removal of topoisomerase III has no effect on the accumulation of catenated intermediates of DNA replication, even when topoisomerase IV activity is removed. Either recQ or recA null mutations, but not helD null or lexA3, partially rescued the synthetic lethality of the double topoisomerase III/IV mutant, indicating a role for topoisomerase III in recombination. We find a bias against deleting the gene encoding topoisomerase III in ruvC53 or ΔruvABC backgrounds compared with the isogenic wild‐type strains. The topoisomerase III RuvC double mutants that can be constructed are five‐ to 10‐fold more sensitive to UV irradiation and mitomycin C treatment and are twofold less efficient in transduction efficiency than ruvC53 mutants. The overexpression of ruvABC allows the construction of the topoisomerase III/IV double mutant. These data are consistent with a role for topoisomerase III in disentangling recombination intermediates as an alternative to RuvABC to maintain the stability of the genome.


Journal of Physics: Condensed Matter | 2006

Exploring writhe in supercoiled minicircle DNA

Jonathan M Fogg; Natalia G. Kolmakova; Ian Rees; Sergei Magonov; Helen G. Hansma; John J. Perona; E. Lynn Zechiedrich

Using λ-Int recombination in E. coli, we have generated milligram quantities of supercoiled minicircle DNA. Intramolecular Int recombination was efficient down to lengths ~254 bp. When nicked and religated in the presence of ethidium bromide, 339 bp minicircles adopted at least seven unique topoisomers that presumably correspond to ΔLk ranging from 0 to -6, which we purified individually. We used these minicircles, with unique ΔLk, to address the partition into twist and writhe as a function of ΔLk. Gel electrophoresis and atomic force microscopy revealed progressively higher writhe conformations in the presence of 10 mM CaCl(2) or MgCl(2). From simplistic calculations of the bending and twisting energies, we predict the elastic free energy of supercoiling for these minicircles to be lower than if the supercoiling was partitioned mainly into twist. The predicted writhe corresponds closely with that which we observed experimentally in the presence of divalent metal ions. However, in the absence of divalent metal ions only limited writhe was observed, demonstrating the importance of electrostatic effects on DNA structure, when the screening of charges on the DNA is weak. This study represents a unique insight into the supercoiling of minicircle DNA, with implications for DNA structure in general.


Antimicrobial Agents and Chemotherapy | 2004

A Mutation in Escherichia coli DNA Gyrase Conferring Quinolone Resistance Results in Sensitivity to Drugs Targeting Eukaryotic Topoisomerase II

Thomas Gruger; John L. Nitiss; Anthony Maxwell; E. Lynn Zechiedrich; Peter Heisig; Siegfried Seeber; Yves Pommier; Dirk Strumberg

ABSTRACT Fluoroquinolones are broad-spectrum antimicrobial agents that target type II topoisomerases. Many fluoroquinolones are highly specific for bacterial type II topoisomerases and act against both DNA gyrase and topoisomerase IV. In Escherichia coli, mutations causing quinolone resistance are often found in the gene that encodes the A subunit of DNA gyrase. One common site for resistance-conferring mutations alters Ser83, and mutations to Leu or Trp result in high levels of resistance to fluoroquinolones. In the present study we demonstrate that the mutation of Ser83 to Trp in DNA gyrase (GyrS83W) also results in sensitivity to agents that are potent inhibitors of eukaryotic topoisomerase II but that are normally inactive against prokaryotic enzymes. Epipodophyllotoxins, such as etoposide, teniposide and amino-azatoxin, inhibited the DNA supercoiling activity of GyrS83W, and the enzyme caused elevated levels of DNA cleavage in the presence of these agents. The DNA sequence preference for GyrS83W-induced cleavage sites in the presence of etoposide was similar to that seen with eukaryotic type II topoisomerases. Introduction of the GyrS83W mutation in E. coli strain RFM443-242 by site-directed mutagenesis sensitized it to epipodophyllotoxins and amino-azatoxin. Our results demonstrate that sensitivity to agents that target topoisomerase II is conserved between prokaryotic and eukaryotic enzymes, suggesting that drug interaction domains are also well conserved and likely occur in domains important for the biochemical activities of the enzymes.


Journal of Physics: Condensed Matter | 2006

Electrostatics of DNA–DNA juxtapositions: consequences for type II topoisomerase function

Graham L. Randall; B. Montgomery Pettitt; Gregory Buck; E. Lynn Zechiedrich

Type II topoisomerases resolve problematic DNA topologies such as knots, catenanes, and supercoils that arise as a consequence of DNA replication and recombination. Failure to remove problematic DNA topologies prohibits cell division and can result in cell death or genetic mutation. Such catastrophic consequences make topoisomerases an effective target for antibiotics and anticancer agents. Despite their biological and clinical importance, little is understood about how a topoisomerase differentiates DNA topologies in a molecule that is significantly larger than the topoisomerase itself. It has been proposed that type II topoisomerases recognize angle and curvature between two DNA helices characteristic of knotted and catenated DNA to account for the enzymes preference to unlink instead of link DNA. Here we consider the electrostatic potential of DNA juxtapositions to determine the possibility of juxtapositions occurring through Brownian diffusion. We found that despite the large negative electrostatic potential formed between two juxtaposed DNA helices, a bulk counterion concentration as small as 50 mM provides sufficient electrostatic screening to prohibit significant interaction beyond an interhelical separation of 3 nm in both hooked and free juxtapositions. This suggests that instead of electrostatics, mechanical forces such as those occurring in anaphase, knots, catenanes, or the writhe of supercoiled DNA may be responsible for the formation of DNA juxtapositions.


Journal of Biological Chemistry | 2000

Roles of Topoisomerases in Maintaining Steady-state DNA Supercoiling in Escherichia coli

E. Lynn Zechiedrich; Arkady B. Khodursky; Sophie Bachellier; Robert Schneider; Dongrong Chen; David M. J. Lilley; Nicholas R. Cozzarelli


Proceedings of the National Academy of Sciences of the United States of America | 2006

Quorum sensing and multidrug transporters in Escherichia coli

Shirley Yang; Christopher R. Lopez; E. Lynn Zechiedrich


Journal of Antimicrobial Chemotherapy | 2003

Relative contributions of the AcrAB, MdfA and NorE efflux pumps to quinolone resistance in Escherichia coli

Shirley Yang; Sonia Rahmati Clayton; E. Lynn Zechiedrich


Genes & Development | 2001

Topoisomerase IV, alone, unknots DNA in E. coli

Richard W. Deibler; Sonia Rahmati; E. Lynn Zechiedrich


Journal of Molecular Biology | 2006

Topological Information Embodied in Local Juxtaposition Geometry Provides a Statistical Mechanical Basis for Unknotting by Type-2 DNA Topoisomerases

Zhirong Liu; Jennifer K. Mann; E. Lynn Zechiedrich; Hue Sun Chan

Collaboration


Dive into the E. Lynn Zechiedrich's collaboration.

Top Co-Authors

Avatar

Jonathan M. Fogg

Baylor College of Medicine

View shared research outputs
Top Co-Authors

Avatar

Shirley Yang

Baylor College of Medicine

View shared research outputs
Top Co-Authors

Avatar

Erol Bakkalbasi

Baylor College of Medicine

View shared research outputs
Top Co-Authors

Avatar

Brian E. Gilbert

Baylor College of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sonia Rahmati

Baylor College of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge